Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week

Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. A big welcome to everyone coming to Chicago for ASCO this weekend. Say hi if you’re attending our STAT event on Friday night!

Read the rest…

Read Original Article: Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week »

About The Author